[Nonspecific immunotherapy using 2,4,6-trimethylhydroxypyrimidine (OPM-111) in Mycoplasma arthritidis infection in mice].
Intraperitoneal infection of mice with M. anthritidis resulted in development of necrotic lesions in the omentum, mesentery and perirenal fatty tissue. The effect of 2,4,6-trimethyloxypyrimidine on such affections was studied. It was shown that the drug had immunomodulating properties and prevented development of lesions caused by Mycoplasma.